Your browser doesn't support javascript.
loading
A 39 kb structural variant causing Lynch Syndrome detected by optical genome mapping and nanopore sequencing.
Bjørnstad, Pål Marius; Aaløkken, Ragnhild; Åsheim, June; Sundaram, Arvind Y M; Felde, Caroline N; Østby, G Henriette; Dalland, Marianne; Sjursen, Wenche; Carrizosa, Christian; Vigeland, Magnus D; Sorte, Hanne S; Sheng, Ying; Ariansen, Sarah L; Grindedal, Eli Marie; Gilfillan, Gregor D.
  • Bjørnstad PM; Department Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Aaløkken R; Department Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Åsheim J; Department Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Sundaram AYM; Department Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Felde CN; Department Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Østby GH; Department Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Dalland M; Department Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Sjursen W; Department of Clinical & Molecular Medicine, NTNU and Department of Medical Genetics, St Olavs Hospital, Trondheim, Norway.
  • Carrizosa C; Department Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Vigeland MD; Department Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Sorte HS; Department of Forensic Sciences, Oslo University Hospital, 0372, Oslo, Norway.
  • Sheng Y; Department Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Ariansen SL; Department Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Grindedal EM; Department Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Gilfillan GD; Department Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
Eur J Hum Genet ; 2023 Nov 29.
Article en En | MEDLINE | ID: mdl-38030917
ABSTRACT
Lynch Syndrome (LS) is a hereditary cancer syndrome caused by pathogenic germline variants in one of the four mismatch repair (MMR) genes MLH1, MSH2, MSH6 and PMS2. It is characterized by a significantly increased risk of multiple cancer types, particularly colorectal and endometrial cancer, with autosomal dominant inheritance. Access to precise and sensitive methods for genetic testing is important, as early detection and prevention of cancer is possible when the variant is known. We present here two unrelated Norwegian families with family histories strongly suggestive of LS, where immunohistochemical and microsatellite instability analyses indicated presence of a pathogenic variant in MSH2, but targeted exon sequencing and multiplex ligation-dependent probe amplification (MLPA) were negative. Using Bionano optical genome mapping, we detected a 39 kb insertion in the MSH2 gene. Precise mapping of the insertion breakpoints and inserted sequence was performed by low-coverage whole-genome sequencing with an Oxford Nanopore MinION. The same variant was present in both families, and later found in other families from the same region of Norway, indicative of a founder event. To our knowledge, this is the first diagnosis of LS caused by a structural variant using these technologies. We suggest that structural variant detection be performed when LS is suspected but not confirmed with first-tier standard genetic testing.

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article